The Profit Equation: Using Analytics to Solve for Growth in Medtech

Posted by Bhargav Mantha on October 16, 2018

As my colleague Brian Chapman pointed out in his recent blog post, Silicon Valley has started disrupting healthcare, putting even more pressure on medtech to rethink the traditional business model and to work differently with healthcare providers and consumers. As the industry continues to think of ways to innovate, it should not lose sight of what funds innovation and long-term growth: profitability.


>
Read More

Three Takeaways From AdvaMed’s 2018 MedTech Conference

Posted by Brian Chapman on October 4, 2018

Last month, the medtech community descended on the city of Philadelphia for AdvaMed’s annual MedTech Conference. Spending most of my time working in the commercial arena, I get to hit the pause button at this event to ponder bigger trends in the industry and to get exposure to some of the other forces shaping our environment in the form of regulatory, legal, trade and lobbying. Now that I’ve had my annual dose of relatively uninterrupted contemplation, I wanted to share three takeaways.


>
Read More

The Apple Watch Wake-Up Call

Posted by Brian Chapman on September 20, 2018

By now, we’ve all heard the latest digital health news: Apple secured FDA clearance for its EKG app on the newest Apple Watch. The tech giants are coming! The end is near!


>
Read More

Living on a Slope: Agile Commercial Strategies for IDN Success

Posted by Bret Caldwell on September 13, 2018

This post was originally published on the Medtech Conference (AdvaMed) blog

By now it’s hard to find a medtech company that doesn’t have a commercial strategy in the U.S. to improve its contracting and sales performance with integrated delivery networks (IDNs).


>
Read More

A View From the Other Side: Four Lessons for Medtech Startups From OutcomeMD

Posted by Tobi Laczkowski on May 23, 2018

Maurice Solomon co-wrote this blog post with Tobi Laczkowski.

We recently published a Q&A with Tim Schmid, the chief strategic customer officer at the Johnson & Johnson Medical Devices Companies. He provided an excellent overview of the changing healthcare market, and how J&J and other large medtech companies are pivoting along with it. 


>
Read More